Skip to main content
Advances in Pharmacological and Pharmaceutical Sciences logoLink to Advances in Pharmacological and Pharmaceutical Sciences
. 2022 Nov 26;2022:4179487. doi: 10.1155/2022/4179487

Artocarpus hirsutus Lam Leaf Extract-Evaluation of Analgesic and Anti-Inflammatory Activity

M Karthik 1, Ullas Prakash D'Souza 1,, Prasanna Shama Khandige 1, Vandana Sadananda 2, S Gowrish 2, Savadamoorthi Kamatchi Subramani 3
PMCID: PMC9719437  PMID: 36471794

Abstract

The study involved extraction, identification, and evaluation of pharmacological activities of the phytochemicals present. Artocarpus hirsutus Lam, commonly known as Wild jack is a greatly valued medicinal plant, which belongs to the plant family Moraceae. Preliminary phytochemical screening studies indicated the presence of flavonoids, saponins, tannins, glycosides, and alkaloids. This study estimated the analgesic and anti-inflammatory prospective of ethanolic leaf extract of Artocarpus hirsutus Lam. The findings showed that at various doses of 100, 200, and 400 mg/kg body weight when administered orally to rats, analgesic effects were produced, also the anti-inflammatory effect studied by carrageenan-induced rat paw edema test showed major anti-inflammatory action. The result indicates that the leaf extract of Artocarpus hirsutus Lam possesses major analgesic and anti-inflammatory activity and therefore requires further investigations to better understand the mechanism of action.

1. Introduction

Inflammation and pain are manifestations of many diseases including oral diseases. Commonly used drugs in such scenarios include nonsteroidal anti-inflammatory drugs (NSAIDs) and opiates. However adverse reactions are observed on the administration of these drugs such as renal damage, respiratory depression, gastrointestinal disturbances, renal damage, and including dependence [110]. This has led the thought process of the researchers towards natural plants and ayurvedic medicine science which would serve as novel anti-inflammatory and analgesic drugs with possibly exhibition of fewer side effects [120].

Artocarpus hirsutus lam is a tropical evergreen tree belonging to the genus Artocarpus and Moraceae family extensively known for its edible fruit and wood. Artocarpus hirsutus Lam is native to India, primarily in South India. Artocarpus hirsutus Lam is an evergreen canopy tree that can grow to a height of 35 m and about 4.5 m in girth. The various morphological parts of the plant are effective against skin diseases, intrinsic haemorrhage, and poisons; bark infusion is used to cure small pimples and cracks present on the skin. The powdered bark is used to treat sores, dried leaves are applied to buboes and hydrocele [2167].

The present research work aimed to identify and isolate the phytoconstituents from the ethanolic leaf extract of Artocarpus hirsutus Lam and evaluate the analgesic and anti-inflammatory activities.

2. Methodology

2.1. Plant Leaf Collection, Authentication and Extraction

The leaves of the plant Artocarpus hirsutus Lam collected from Deralakatte, Mangaluru, Karnataka were authenticated by a botanist. The fresh leaves were sun dried and subsequently pulverized using a mechanical grinder. The dry powder was macerated in ethanol for a duration of 7 days with occasional stirring. The total extracts of the leaves were distilled, filtered, concentrated using a rotary evaporator, and stored in a desiccator.

2.2. Preliminary Qualitative Phytochemical Investigations

Presence of diverse phytochemicals in the total extracts of the leaves of Artocarpus hirsutus Lam was assessed by qualitative test for preliminary phytoconstituents.

2.2.1. Test for Alkaloids

(1) Dragendrof f's Test. In 5 mL of distilled water, 0.5 g of ethanolic leaf extract was dissolved, to which 2 M hydrochloric acid was added for the reaction to initiate. Subsequently, Dragendroff's reagent (1 mL) was added to the above solution. An orange red precipitate indicates the presence of alkaloids.

(2) Hager's Test. Hager's reagent was added to 1 mL of ethanolic extract of leaves. Yellowish colored precipitate formed confirms the presence of alkaloids.

(3) Wagner's Test. 1.5 mL of hydrochloric acid was added to 1 mL of ethanolic extract of the leaf. Subsequently few drops of Wagner's reagent were added. Buff colored precipitate formation indicates the presence of alkaloids.

(4) Mayer's Test. Mayer's reagent was added to 1 mL of ethanolic extract. The presence of alkaloids was confirmed by observing the formation of pale yellow or white precipitate.

2.2.2. Test for Reducing Sugar

(1) Molisch Test. Freshly prepared 20% alcoholic α-naphthol was added to 2 mL of the leaf extract to which 2 mL of concentrated sulphuric acid was added dropwise along the walls of the test tube to facilitate the formation of a layer and to avoid mixing. The formation of the purple ring at the layer formed is an indication for the presence of carbohydrates which vanishes on the addition of an excess of an alkaline reagent.

(2) Benedict's Test. Benedict's solution was added to the leaf ethanolic extract and heated. The formation of a brick red color confirms the presence of carbohydrates.

(3) Fehling's Test. 10 mg of the ethanolic leaf extract was dissolved in 1 mL of water. 1 mL of Fehling's A and Fehling's B solution were added. The presence of reducing sugar was confirmed by observing the formation of brick red color.

(4) Tollen's Test. In 1 mL of water 10 g of ethanolic leaf extract was dissolved. 1 mL of Tollen's solution was added and heated on a water bath. The formation of a black precipitate or black silver mirror along the sides of the test tube confirms the existence of reducing sugars.

2.2.3. Test for Flavonoids

(1) Shinoda Test. 0.5 mL of ethanolic leaf extract was heated, and subsequently hydrochloric acid (10 drops) and magnesium powder were added. The color change of the solution to reddish brown proves the presence of flavonoids.

2.2.4. Test for Saponins

10 mg of ethanolic extract was dissolved in water and shaken vigorously. The appearance of foam proves the presence of saponins.

2.2.5. Test for Tannins

To 0.5 g of ethanolic leaf extract, 5 mL of chloroform was added. A reddish pink color formed by the addition of 1 mL of acetic anhydride and 2 drops of sulphuric acid to the solution confirms the presence of tannins.

2.2.6. Tests for Steroids

(1) Liebermann-Burchard's Test. 10 mg of the ethanolic extract was dissolved in acetic anhydride. The solution was heated and cooled. Concentrated sulphuric acid (1 mL) was incorporated slowly, along the side of the test tube. The development of a greenish color confirms the presence of steroids.

(2) Salkowski Reaction. To the ethanolic leaf extract, 1 mL of concentrated sulphuric acid was added along the side of a test tube. The mixture was allowed to stand. The red color formed in the chloroform layer confirms the presence of steroids.

2.2.7. Test for Triterpenoids

The leaf extract was dissolved in acetic anhydride. The solution was heated and allowed to cool. Concentrated sulphuric acid (1 mL) was added along the sides of the test tube. Violet color formation confirms the presence of triterpenoids.

2.2.8. Test for Glycosides

(1) Molisch Test. 2 mg of ethanolic leaf extract was dissolved in 10 mL of water which was shaken and filtered. To the concentrated filtrate 2 to 3 drops of Molisch reagent was added, mixed, and subsequently concentrated sulphuric acid (2 mL) was added along the sides of the test tube. Reddish-violet ring proved the presence of glycosides.

2.2.9. Test for Resins

A few drops of acetone were added to 1 mL ethanolic extract and dissolved. This solution was added to distilled water. Turbidity confirms the presence of resins.

2.3. Pharmacological Investigations

2.3.1. Selection of Animals

Male albino rats, Wistar strain of 4–6 weeks weighing (150–200 g), albino mice (25–30 g) were obtained from central animal house NUCARE, Derlakatte, Mangaluru for the study after obtaining approval from the Institutional Ethics Committee for animal experimentation. Animals were grouped and housed in cages and maintained under basic laboratory conditions (temperature 20–25°C) with dark and light cycle (12 h/12 h). They were fed a basic dry pellet diet and water ad libitum. All investigations and experiments were conducted based on the guidelines of the Committee for the Intent of Control and Supervision of Experiments on Animals (CPCSEA), New Delhi, India and was affirmed by the Institutional Animal Ethics Committee (IAEC) of NGSM Institute of Pharmaceutical Sciences–NGSMIPS/IACE/MAY-2017/60.

2.3.2. Acute Toxicity Studies

Preliminary pharmacological studies were carried out to evaluate the acute toxicity and LD50 of the ethanolic extract of the leaves of Artocarpus hirsutus [52, 53]. The acute toxicity studies were conducted in adult male albino rats which were weighing about 150–200g, by the “up and down” method (OECD guidelines 425). Overnight fasted animals were given ethanolic leaves extract at a dose of 2000 mg/kg body weight orally. The animals were noticed for the next 4 hours for the general behavioral changes, neurological profile, and autonomic profiles, and last for death after 24 hours. The result attained was tabulated in Irwin's table.

The following check list are selected for this:

  • (i)
    Behavioral profile
    •   Awareness-alertness, passivity, stereotype, visual placing
    •   Mood-fearfulness, grooming, irritability, restlessness
  • (ii)
    Neurological profile
    •   Motor activity-corneal reflex, gait, grip, pain response, reactivity, startle response, spontaneous response, touch response, and tremor
  • (iii)
    Autonomic profile
    •   Defecation, heart rate, pilo erection, respiratory rate, urination, and writhing

2.3.3. Dose Selection

For conducting analgesic and anti-inflammatory activity, three dose levels were selected [53]. The middle dose was approximately 1/10th of the maximum dose which was administered while evaluating acute toxicity (i.e., 1/10th of 2000 mg/kg body weight–200 mg/kg body weight), and the high dose was twice that of 1/10th dose (i.e., 400 mg/kg body weight) and a low dose which was of 50% of 1/10th dose (i.e., 100 mg/kg body weight) was administered. The dried crude ethanolic leaves extract of Artocarpus hirsutus Lam was suspended in 2% w/v of Gum acacia in normal saline for administration orally.

2.3.4. Assessment of In VitroAnti-Inflammatory Activity Inhibition of Albumin Denaturation

The reaction mixture (5 mL) containing 0.2 mL of egg albumin, phosphate buffer saline 2.8 mL with pH 6.4, and 2 mL of ethanolic leaves extract of different concentration was taken with a final concentration of 31.25, 62.5, 125, 250, 500, and 1000 μg/mL [5467]. Distilled water was taken as blank/control which had a similar volume as that of the reaction mixture. Both these mixtures were incubated at 37 ± 2°C in an incubator for 15 min and then heated for 5 min at a temperature of 70°C. After cooling, absorbance was measured at 660 nm. Diclofenac sodium as a reference at concentrations 78.125, 156.25, 312.5, 625, 1250, and 2500 μg/mL was treated similarly, and absorbance was measured.

(1) Evaluation. The turbidity formed was measured spectrophotometrically at 660 nm. The calculation for percentage inhibition of protein denaturation was done by the following formula:

%inhibition=1vtvc×100, (1)

where Vt = absorbance of test sample, Vc = absorbance of control.

2.3.5. In Vivo Methods to Detect Analgesic and Anti-Inflammatory Activity

(1) Analgesic Activity. Tail immersion method.

  •   Group I: control

  •   Group II: standard, Pentazicine (10 mg/kg)

  •   Group III: test drug (100 mg/kg)

  •   Group IV: test drug (200 mg/kg)

  •   Group V: test drug (400 mg/kg)

The tails of the albino rats (Table 1) were gently immersed in a thermostatic organ bath with a temperature maintained at 55 ± 10°C. The animals which withdrew the tail from hot water within 3–5 seconds were selected for the test. The reaction time of all animals towards thermal heat was noted. Group III, Group IV, and Group V animals were administered ethanolic extract in 2% w/v Gum acacia in normal saline orally. Group II was given the standard drug Pentazocine (10 mg/kg) intraperitoneally and Group I received 2% w/v of Gum acacia (2 mL/kg) with normal saline.

Table 1.

Material and method.

Animals Albino rat
Sex Male/female
Body weight 150–200 g
Number of groups 5
Number of animals in each group 6
Vehicle Normal saline
Route of administration Standard-i.p, test-p.o
Water and food Ad libitum

(2) Evaluation. Animals from all the groups were exposed to hot water subsequent to the administration of the test and reference compounds. Reaction time was noted at 30 and 90 mins interval, also the reaction time was noted as and when the animals withdrew their tail completely from the hot water bath. The mean reaction time in each group was evaluated statistically.

%increaseinreactiontime=RTATRTBT1×100. (2)

RTAT and RTBT are the reaction time after treatment and before treatment, respectively.

Acetic acid induced writhing method [56].

  •   Group I: control.

  •   Group II: standard, Diclofenac sodium (10 mg/kg)

  •   Group III: test drug (100 mg/kg)

  •   Group IV: test drug (200 mg/kg)

  •   Group V: test drug (400 mg/kg)

The first group of animals were administered acetic acid 06% v/v. i.p., which were considered as control. The second group was administered the standard drug Diclofenac sodium (10 mg/kg body weight, i.p). The third, fourth and fifth group animals were administered 100, 200, and 400 mg/kg body weight ethanolic extract which was suspended with 2% gum acacia 30 min prior (Table 2).

Table 2.

Material and method: chemical induced writhing method.

Animal Albino mice
Sex Male/female
Body weight 20–25 g
Number of groups 5
Number of animals in each group 6
Vehicle Normal saline
Route of administration Standard-i.p., test-p.o
Water and food Ad libitum

(3) Evaluation. The writhing action was indicated by the stretching of the abdomen along with the simultaneous stretching of at least one hind limb. This action was observed for 30 min. Percentage inhibition calculation was carried out by using the following formula:

percentageinhibition=1RtTc×100. (3)

Rt = Mean number of writhes in treated groups, Rc = Mean number of writhes in control groups.

Anti-inflammatory screening method Carrageenan induced rat paw edema method [57].

  •   Group I: control

  •   Group II: standard, Diclofenac sodium (10 mg/kg)

  •   Group III: test drug (100 mg/kg)

  •   Group IV: test drug (200 mg/kg)

  •   Group V: test drug (400 mg/kg)

Albino rats weighing between 150–200 g were taken for the test. Prior to the day of the experiment the animals were starved overnight with water ad libitum. An identification mark was made on both the hind paws just below the tibio-tarsal junction. Each time the paw was dipped up to the mark into the mercury column of the plethysmograph to get constant paw volume. The second group was administered a standard drug, Diclofenac sodium 10 mg/kg body weight. The third, fourth and fifth groups received ethanolic leaves extract at 100, 200, and 400, respectively. Acute inflammation was induced after thirty minutes of administration of the drug by injecting into the subplantar region of the left hind paw 0.1 mL of 1% carrageenan (Table 3).

Table 3.

Material.

Animal Albino mice
Sex Male/female
Body weight 20–25 g
Number of groups 5
Number of animals in each group 6
Vehicle Normal saline
Route of administration Standard-i.p, test-p.o
Water and food Ad libitum

(4) Evaluation. The paw volume was measured with the use of a plethysmograph at 0, 0.5, 1, 2, and 3 hours subsequent to the carrageenan injection. The difference between 0 hour and consequent readings was considered as edema volume. The calculation for percentage inhibition of edema was carried out by using the following formula:

%edemainhibition=1VtVc×100. (4)

Vt = volume of paw edema in drug treated group Vc = volume of paw edema in control group.

(5) Statistical Analysis. The data obtained were evaluated using one way analysis of variance (ANOVA), followed by posthoc test (Scheffe's T-Test) using graph pad SPSS software version 16.0 where p value less than 0.05 was taken as statistically significant.

3. Results

3.1. Preliminary Phytochemical Analysis of Ethanolic Extract of Artocarpus hirsutus Lam

Phytochemical analysis results Table 4).

Table 4.

Phytochemical analysis results.

Test Result
Alkaloids
 a Dragendroff's test +ve
 b Hager's test +ve
 c Wagner's test +ve
 d Mayer's test +ve
Carbohydrates
 a Molisch's test +ve
 b Benedict's test +ve
 c Fehlings's test +ve
Flavonoids +ve
Saponins +ve
Tannins +ve
Steroids -salkowaski test +ve
Glycosides -Molisch's test +ve
Resins −ve

3.2. Acute Toxicity Studies

The ethanolic extract of leaves of Artocarpus hirsutus Lam up to 2000 mg/kg body weight by the oral route of administration were found to be safe. Even after 24 hours the animals were found to be well tolerated. There was no indication of toxicity and death. Three doses, 100 mg/kg, 200 mg/kg, and 400 mg/kg body weight were selected for the experiment.

3.3. Analgesic Activity

Effect of ethanolic extract of Artocarpus hirsutus Lam on tail immersion method Tables 5 and 6).

Table 5.

Effect of ethanolic extract of Artocarpus hirsutus Lam on tail immersion method.

Group Treatment Dose (mg/kg) Reaction time in seconds
Before treatment 30 min 60 min 90 min
I Control 2 1.84 ± 0.03 1.82 ± 0.05 2.85 ± 0.05 3.11 ± 0.4
II Standard 10 2.13 ± 0.12 6.0 ± 0.55a 6.5 ± 0.29a 9.4 ± 0.04a
III Ethanolic extract 100 1.8 ± 0.05 1.58 ± 0.04 2.2 ± 0.08 3.4 ± 0.09
IV Ethanolic extract 200 1.81 ± 0.08 3.3 ± 0.3ab 3.7 ± 0.39ab 4.7 ± 0.59ab
V Ethanolic extract 400 1.9 ± 0.071 4.9 ± 0.088ab 5.9 ± 0.076ab 6.4 ± 0.099ab

p < 0.05 is considered as significant, a = p < 0.05 significant compared to control, b = p < 0.05 significant compared to standard.

Table 6.

Effect of ethanolic extract of Artocarpus hirsutus Lam by acetic acid induced writhing method.

Group Treatment Dose (mg/kg) Number of writhings
Mean ± SEM
I Control 0.1 mL 91 ± 0.36
II Standard (diclofenac) 10 22.3 ± 0.55a
III Ethanolic extract 100 83 ± 0.85
IV Ethanolic extract 200 61.6 ± 1.0ab
V Ethanolic extract 400 53.16 ± 0.47ab

p < 0.05 is considered as significant, a = p < 0.05 significant compared to control, b = p < 0.05 significant compared to standard.

3.4. Anti-Inflammatory Activity

Effect of ethanolic extract of Artocarpus hirsutus Lam on carrageenan induced rat paw edema method Table 7).

Table 7.

Effect of ethanolic extract of Artocarpus hirsutus Lam on carrageenan induced rat paw edema method.

Group Treatment Dose (mg/kg) 30 min 60 min 120 min 180 min
I Control 2 mL/kg 0.55 + 0.04 0.63 ± 0.04 0.64 ± 0.04 0.64 ± 0.03
II Standard 10 mg/kg 0.17 ± 0.02a 0.26 ± 0.04a 0.16 ± 0.02a 0.16 ± 0.03a
III Ethanolic extract 100 mg/kg 0.52 ± 0.02 0.54 ± 0.06 0.51 ± 0.04 0.47 ± 0.06
IV Ethanolic extract 200 mg/kg 0.42 ± 0.03ab 0.47 ± 0.04ab 0.42 ± 0.04ab 0.4 ± 0.03ab
V Ethanolic extract 400 mg/kg 0.31 ± 0.08ab 0.32 ± 0.05ab 0.35 ± 0.07ab 0.25 ± 0.09ab

p < 0.05 is considered as significant, a = p < 0.05 significant compared to control, b = p < 0.05 significant compared to standard.

4. Discussion

The present study was designed to evaluate the analgesic and anti-inflammatory activity of ethanolic leaf extract of Artocarpus hirsutus Lam. The peripheral analgesic activity was carried out using the chemical induced writhing method (Table 6) and central analgesic activity by tail flick using immersion of the tail (Table 5). The carrageenan induced paw edema model was carried out to identify the acute inflammatory activity.

Preliminary phytochemical screening of ethanolic leaves extract of Artocarpus hirsutus Lam signifies the presence of saponins, tannins, flavonoids, triterpenoids, glycosides, alkaloids, and resins (Table 4). When the ethanolic extract of the leaves were administered orally at the doses of 200 and 400 mg/kg, significant analgesic activity was exhibited (p < 0.05) by inhibition of writhing induced by acetic acid in the mice. The writhing is associated to the increase in levels of PGE2 and PGF2 in the peritoneal fluid and elevation in levels of lipoxygenase products by the peritoneal injection of acetic acid [60]. Acetic acid induced writhing methods also release endogenous substances like bradykinin, histamine, and serotonin, which activates the sensory nerve endings [61]. Antinociceptive action of ethanolic extract of Artocarpus hirsutus Lam leaves could be due to its action on visceral receptors which are reactive to acetic acid thereby preventing prostaglandin synthesis.

In the tail immersion test the pain produced by the thermal stimulus is characteristic for central-mediated activity [62]. Opioid agents like morphine bring about analgesic action via supra spinal and spinal receptors [63]. This activity could be due to the stimulation of the periaqueductal gray matter area to discharge endogenous peptides [64]. These endogenous peptides crash the spinal cord and inhibit pain impulse transmission at the synapse in the dorsal horn. The possible actions of ethanolic extract of Artocarpus hirsutus Lam leaves may be due to its action on the central receptors or promoted discharge of endogenous opioid peptides. In this study, the action of the drug extract at a dose of 100 mg/kg was not significant. But it showed a significant increase (p < 0.05) at a dose of 200 mg/kg body weight and tail flick latency was highest (p < 0.05) at a dose of 400 mg/kg body weight at 90 min. Hence an expressive increase in reaction time and decrease in writhing are generally taken as significant parameters of analgesic activity in the heat conduction method and acetic acid induced writhing test respectively.

The carrageenan technique was chosen due to its sensitivity in identifying anti-inflammatory agents which are orally active, mainly in the acute stage of inflammation. Carrageenan is used to produce acute inflammation and is biphasic. The initial phase (0–2.5 hours after carrageenan injection) mainly occurs due to the concordant release of mediators such histamine, kinins, and serotonin. The next phase is related with an increase in the production of prostaglandin, oxygen derived free radicals, and inducible cyclooxygenase production [65, 66]. The carrageenan induced paw edema method in rats is avowed to be reactive to cyclooxygenase (COX) inhibitors as well as lipoxygenase inhibitors thereby restricting the enzyme COX involved in the synthesis of prostaglandins. When compared to the control, the dose of 400 mg/kg body weight at 30, 60, 120, and 180 minutes showed a significant inhibition (p < 0.05) of rat paw edema induced by carrageenan, respectively (Table 7). Based on the result it can be concluded that the inhibitory action of ethanolic leaves extract on Carrageenan induced inflammation in rat paw may be because of the restriction of the enzyme cyclooxygenase which further leads to restriction in the synthesis of prostaglandin (Tables 8 and 9).

Table 8.

Absorbance of ethanolic extract of Artocarpus hirsutusn Lam leaves at 660 nm.

Concentration Absorbance % inhibition
Control 0.04
31.25 0.066 65
62.5 0.073 82.5
125 0.079 97.5
250 0.083 107.5
500 0.094 135
1000 0.103 157.5

Table 9.

Absorbance of standard (diclofenac sodium).

Concentration Absorbance % inhibition
Control 0.04
78.125 0.025 29
156.25 0.063 57.5
312.5 0.072 80
625 0.110 175
1250 0.122 205
2500 0.13 225

The denaturation of protein method was selected for the evaluation of in vitro anti-inflammatory activity of the ethanolic extract of Artocarpus hirsutus Lam. Tissue protein denaturation is the main causes of inflammatory and arthritic disease. Substances that restrict the denaturation of protein are meritorious in the anti-inflammatory drug development [67]. From the results, it can be deduced that the ethanolic extract of Artocarpus hirsutus Lam is more effective in less concentration than that of diclofenac sodium and thus it has anti-inflammatory activity.

5. Conclusion

Artocarpus hirsutus Lam has been used in folklore, Ayurvedic and traditional medicines for the treatment of numerous health concerns. Through this study, the phytoconstituents present in ethanolic leaf extracts of Artocarpus hirsutus Lam were identified. Using animal models, it was concluded to have good analgesic and anti-inflammatory potential. This study should enable researchers to identify and isolate new constituents from Artocarpus hirsutus Lam, understand the mechanism of action of the phytoconstituents and formulation of drugs for various diseases.

Acknowledgments

The authors thank Dr K V Nagalakshma, Head of the Department, Department of Botany, St Aloysius College (Autonomous), Mangaluru, Karnataka, India for authenticating the plant leaves.

Data Availability

The data used to support the study are included in the paper.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

References

  • 1.Vikram P. K., Malvi R., Jain D. K. Evaluation of analgesic and anti- inflammatory potential of Mimosa pudica Linn. International Journal of Current Pharmaceutical Research . 2012;4(4):49–52. [Google Scholar]
  • 2.Anonymous. General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine . Geneva.Switzerland: WHO; 2001. [Google Scholar]
  • 3.Kurian J. C., Speedie M. K. Pharmacogonosy and Pharmacobiotechnology . 7thed. Pune, India: Oriental Watchman Publishing House; 1996. [Google Scholar]
  • 4.Sandhya S., Kumar S. P., Vinod K. R., Banji D., Kumar K., Rajeshwar T. Ova angiogenesis analgesic and anti- inflammatory potency of Aerva monsoniae (Amaranthaceae) Asian Pacific Journal of Tropical Disease . 2012;2:385–389. [Google Scholar]
  • 5.Pal S. K., Shukla Y. Herbal medicine: current status and the future. Asian Pacific Journal of Cancer Prevention . 2003;4(4):281–288. [PubMed] [Google Scholar]
  • 6.Seth S. D., Sharma B. Medicinal plants in India. Indian Journal of Medical Research . 2004;120(1):9–11. [PubMed] [Google Scholar]
  • 7.Who. General Guideline for Methodologies on Research and Evaluation of Traditional Medicine. WHO/EDM/TRM/2000 . Vol. 1. Geneva.Switzerland: WHO; 2000. p. p. 24. [Google Scholar]
  • 8.Gogtay N. J., Bhatt H. A., Dalvi S. S., Kshirsagar N. The use and safety of non-allopathic Indian medicines. Drug Safety . 2002;25(14):1005–1019. doi: 10.2165/00002018-200225140-00003. [DOI] [PubMed] [Google Scholar]
  • 9.Nemmani K. V. S., Jena G. B., Dey C. S., Kaul C. L., Ramarao P. Cell proliferation and natural killer cell activity by polyherbal formulation, Immu-21 in mice. Indian Journal of Experimental Biology . 2002;40(3):282–287. [PubMed] [Google Scholar]
  • 10.Jena G. B., Nemmani K. V. S., Kaul C. L., Ramarao P. Protective effect of a polyherbal formulation (Immu-21) against cyclophosphamide-induced mutagenicity in mice. Phytotherapy Research . 2003;17(4):306–310. doi: 10.1002/ptr.1125. [DOI] [PubMed] [Google Scholar]
  • 11.American pain society. Principles of analgesic use in the treatment of acute pain and chronic cancer pain. Clinical Pharmacist . 1990;9:p. 601. [PubMed] [Google Scholar]
  • 12.Vane J., Botting R. Inflammation and the mechanism of action of anti‐inflammatory drugs. The FASEB Journal . 1987;1(2):89–96. doi: 10.1096/fasebj.1.2.3111928. [DOI] [PubMed] [Google Scholar]
  • 13.Majagi S., Karnad A., Patil P. Calcium enhances anti-inflammatory activity of aspirin in albino rats. Indian Journal of Pharmacology . 2006;38(6):p. 397. doi: 10.4103/0253-7613.28205. [DOI] [Google Scholar]
  • 14.Kumar S. S., Marella S. S., Sharmistha M. Evaluation of analgesic and anti- inflammatory activity of abutilon indicium. International Journal of Drug Development & Research . 2013;5(1):99–102. [Google Scholar]
  • 15.Jagtap U., Bapat V. Artocarpus: a review of its traditional uses, phytochemistry and pharmacology. Journal of Ethnopharmacology . 2010;129(2):142–166. doi: 10.1016/j.jep.2010.03.031. [DOI] [PubMed] [Google Scholar]
  • 16.AkhilHari R. K. G., Divya D. Artocarpus: a review of its phytochemistry and pharmacology. Journal of PharmaSearch . 2014;9(1):7–12. [Google Scholar]
  • 17.Anu V., Methi R. S., Mujeeb C. A., Vinod M. K. Biosynthesis of silver nanoparticle from Artocarpus hirsutus leaves extracts its antimicrobial activity and phytochemical analysis. International Journal of Research in Pharmaceutical and Nano Sciences . 2005;4(1):28–39. [Google Scholar]
  • 18.DibinLal D. Seethadevi B. Antiulcer activity of the bark of Artocarpus hirsutus lam. Journal of Pharma Search . 2013;8(2):3–5. [Google Scholar]
  • 19.VinaySuvarna M. N., Venkatachalapathy R., MakariHanumanthappa K., Ramesh B. S. Phytochemical and antimicrobial activity of Artocarpus hirsutus: an InVitroStudy. International Journal Of Pharm Bioscience . 2014;5(3):98–104. [Google Scholar]
  • 20.Sireesha K., Raghunandan N. Evaluation of InVivoAntidiabetic and Antioxidant activity of Artocarpus hirsutus seeds in streptozotocin induced diabetic rats. AJPCR . 2016;9(5):1–4. [Google Scholar]
  • 21.Shyma T. B., Devi Prasad A. G. Traditional use of Medicinal Plants and its status among the tribes in Mananthavady of wayanad district, Kerala. World Research Journal of medicinal aromatic plants . 2012;1(2):22–26. [Google Scholar]
  • 22.Asha D. S., Ben C. P. International science congress Association25 least concern bark and stipule of Artocarpus species (Moraceae) – an effective antibacterial agent. International Research Journal of Biological Sciences . 2014;3(2):25–29. [Google Scholar]
  • 23.Chandra M., Srividya In vitro anti-inflammatory activity of some Wild fruits of Karnataka. Proceedings of the International Conference on Biological Environment and Food engineering; May, 2015; Bali, Indonesia. pp. 48–50. [Google Scholar]
  • 24.Patel J., Kumar G. S., Satyasai D. GC-MS Analysis of bioactive components on the leaves extract of Artocarpus hirsutus: a Potential folklore medicinal plant. International Journal of Herbal Medicine . 2016;4(6):95–97. [Google Scholar]
  • 25.Sulaiman M. R., Zakaria Z. A., Bujarimin A. S., Somchit M. N., Israf D. A., Moin S. Evaluation ofMoringa oleiferaaqueous extract for antinociceptive and anti-inflammatory activities in animal models. Pharmaceutical Biology . 2008;46(12):838–845. doi: 10.1080/13880200802366710. [DOI] [Google Scholar]
  • 26.Ching F. P., Falodun A., Omogbai E. K. I., Okpo S. O., Ozolua R. T., Iqbal M. Evaluation of analgesic and anti-inflammatory compounds from Stereospermum kunthianum. Int J Pharm Tech Res . 2009;1(4):1065–1068. [Google Scholar]
  • 27.Iwalewa E. O., Iwalewa O. J., Adeboye J. O. Analgesic, antipyretic, anti-inflammatory effects of methanol, chloroform and ether extracts of Vernonia cinerea less leaf. Journal of Ethnopharmacology . 2003;86(2-3):229–234. doi: 10.1016/s0378-8741(03)00081-3. [DOI] [PubMed] [Google Scholar]
  • 28.Khan S., Mehmood M. H., Ali A. N. A., Ahmed F. S., Dar A., Gilani A. H. Studies on anti-inflammatory and analgesic activities of betel nut in rodents. Journal of Ethnopharmacology . 2011;135(3):654–661. doi: 10.1016/j.jep.2011.03.064. [DOI] [PubMed] [Google Scholar]
  • 29.Jimoh A. O., Chika A., Umar M. T., Adebisi I., Abdullahi N. Analgesic effects and anti-inflammatory properties of the crude methanolic extract of Schwenckia americana Linn (Solanaceae) Journal of Ethnopharmacology . 2011;137(1):543–546. doi: 10.1016/j.jep.2011.06.014. [DOI] [PubMed] [Google Scholar]
  • 30.Silva G. N., Martins F. R., Matheus M. E., Leitao S. G., Fernandes P. D. Investigation of anti-inflammatory and antinociceptive activities of Lantana trifolia. Journal of Ethnopharmacology . 2005;100(3):254–259. doi: 10.1016/j.jep.2005.02.040. [DOI] [PubMed] [Google Scholar]
  • 31.Olajide O. A., Makinde J. M., Awe S. O. Effects of the aqueous extract of Bridelia ferruginea stem bark on carrageenan-induced oedema and granuloma tissue formation in rats and mice. Journal of Ethnopharmacology . 1999;66(1):113–117. doi: 10.1016/s0378-8741(99)00006-9. [DOI] [PubMed] [Google Scholar]
  • 32.Manivannan E., Kothai R., Arul B., Rajaram S. Anti-inflammatory activity of bougainvilla spectabilis linn. Research Journal of Pharmaceutical, Biological and Chemical Sciences . 2012;3(1):642–646. [Google Scholar]
  • 33.Shastry M. V., Patil V. R., Chaudhari Y. Acute and chronic anti-inflammatory activity of Pergulari adaemia whole plant in various experimental animal models. Int J Pharm Sci . 2011;3(3):241–244. [Google Scholar]
  • 34.Singh S., Panchaksharimath P., Siddappa D. Evaluation of anti- inflammatory activities of Sida cordifolia Linn in albino rats. Journal of Chemical and Pharmaceutical Research . 2011;3(6):136–142. [Google Scholar]
  • 35.Nayeem N., Karvekar M. D. Effect of plant stages on analgesic and anti- inflammatory activity of the leaves of Tectonia grandis. European Journal of Experimental Biology . 2012;2(2):396–399. [Google Scholar]
  • 36.Rahman M. A., Bachar S. C., Rahmatullah M. Analgesic and anti-inflammatory activity of methanolic extract of Acalypha indica Linn. Pakistan journal of pharmaceutical sciences . 2010;23(3):256–258. [PubMed] [Google Scholar]
  • 37.Gaur K., Rana A. C., Nema R. K., Kori L. M., Sharma S. C. Anti-inflammatory and analgesic activity of hydro-alcoholic leaves extract of Euphorbia nerifolia Linn. Asian Journal of Pharmaceutical and Clinical Research . 2009;2(1):26–29. [Google Scholar]
  • 38.Sharma S., Lakshmi K. S., Patidar A., Chaudhary A., Dhaker S. Studies on anti-inflammatory effect of aqueous extract of leaves ofHoloptelea integrifolia, Planch. in rats. Indian Journal of Pharmacology . 2009;41(2):87–88. doi: 10.4103/0253-7613.51348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Anthony J. A., Oluseyi M. A., Adeolu A. A., Margaret O. S. Anti-inflammatory and analgesic activity of the methanol extract of Malva parviflora Linn (Malvaceae) in rats. African Journal of Biotechnology . 2010;9(8):1225–1229. doi: 10.5897/ajb09.838. [DOI] [Google Scholar]
  • 40.Dutta S., Yadav A., Mariappan G. Analgesic activity of Taxus baccata Linn.bark extract. Int J Pharm bio sci . 201;1(1):1–7. [Google Scholar]
  • 41.Rang H. P., Dale M. M., Ritter J. M., Moore P. K. Text Book of Pharmacology . 5th ed. Edenburg, South Africa: Churchill Livingstone; 2003. [Google Scholar]
  • 42.Dipiro T. J., Talbert L. R., Materia Yee C. G. Pharmacotherapy A Pathophysiologic Approach . 6th ed. China: McGraw-Hill; 2007. [Google Scholar]
  • 43.Vogal G. H. Drug Discovery and Evaluation . 2nd ed. New York, USA: Springer- verlag; 2002. [Google Scholar]
  • 44.Craig A. D., Sorkin L. S. Encyclopedia of life sciences . Hoboken, New Jersey, USA: Wiley-Blackwell; 2001. Pain and Analgesia; pp. 1–7. [Google Scholar]
  • 45.Tripathi K. D. Essentials of Mediacl Pharmacology . 5th ed. New Delhi, India: Jaypee Brothers Medical Publishers; 2003. [Google Scholar]
  • 46.Hare B. D. The opiod analgesics: rational selection of agents for acute and chronic pain. Hospital Formulary . 1987;22:64–86. [Google Scholar]
  • 47.Lippincott J. B. Facts and Comparisons . 4th ed. Philadelphia: Lipincott Williams and Wilkins; 2009. [Google Scholar]
  • 48.Kaplan A., Lavernal L. S. Clinical Chemistry: Interpretation and Techniques . 2nd ed. Philadelphia: Lea & Febiger; 1983. [Google Scholar]
  • 49.Mishra D., Ghosh G., Kumar S., Panda P. S. An experimental study ofnalgesic activity of selective COX-2 inhibitor with conventional NSAIDS. Asian Journal of Pharmaceutical and Clinical Research . 2011;4(1):78–81. [Google Scholar]
  • 50.Hardman J. G., Limbird L. E., Glimen A. G. The Pharmacological Basis of Therapeutics . 10th ed. New York, USA: McGraw-Hill; 2001. [Google Scholar]
  • 51.Pranali P., Balaraju P., Ravikanth V., Swetha M., Shireesha M. Evaluation of anti-pyretic and analgesic activity curculigo orchioides gaertn rhizomes. An International Journal of Advances in Pharmaceutical Sciencs . 2011;2(5-6):444–450. [Google Scholar]
  • 52.Kokate C. K., Purohit P. A., Gokhale B. S. Pharmacology . 22nd ed. Pune, India: Nirali Prakashan; 2003. [Google Scholar]
  • 53.Trease E. G., Evans C. W. Pharmacognosy . 12th ed. Eastbourne, UK: English Language Book Society; 1985. [Google Scholar]
  • 54.Ghosh M. N. Fundamentals of Experimental Pharmacology . 22nd ed. Calcutta, India: Scientific Book Agency; 1984. [Google Scholar]
  • 55.Oecd guidelines. New OECD 425 Guidelines for Testing Animals . Vol. 26. Paris, France: Oecd guidelines; 2001. pp. 1–26. [Google Scholar]
  • 56.Chandra S., Chatterjee P., Dey P., Bhattacharya S. Evaluation of in vitro anti-inflammatory activity of coffee against the denaturation of protein. Asian Pacific Journal of Tropical Biomedicine . 2012;2(1):178–180. doi: 10.1016/s2221-1691(12)60154-3. [DOI] [Google Scholar]
  • 57.Agrahari A. K., Khaliquzzama M., Panda S. K. Evaluation of analgesic activity of methanolic extract of Trapa natans Ivar. Bispinosa roxb. Roots. J curr Pharm Res . 2010;1:8–11. [Google Scholar]
  • 58.Dey N. D., Shankhajith D. E., Ghosh A. K. Evaluation of analgesic activity of methanolic extract of Amorphophallus paeoniifolius tuber by tail flick and acetic acid- induced writhing response method. International Journal of Pharmacy and Biological Sciences . 2010;1(4):662–668. [Google Scholar]
  • 59.Onasanwo S. A., Oyagbemi A. A., Saba A. B. Anti-inflammatory and analgesic properties of the ethanolic extract of Cnidoscolus aconitifolius in rats and mice. Journal of Basic and Clinical Physiology and Pharmacology . 2011;22(1-2):37–41. doi: 10.1515/jbcpp.2011.010. [DOI] [PubMed] [Google Scholar]
  • 60.Ghule R. S., Venkatnarayan R., Thakare S. P., Jain H., Ghule P. R. Analgesic activity of Cuscutta campestris Yunker a parasitic plant grown on Nerium indicum Mill. Journal of Advanced Pharmacy Education & Research . 2011;1:45–51. [Google Scholar]
  • 61.Rathi A., Rao C. V., Khatoon S., Mehrotra S. Ethnopharmacological evaluation of Peristrophe bicalyculata Nees for anti-inflammatory and analgesic activity. Natural Product Sciences . 2003;9:195–199. [Google Scholar]
  • 62.Deraedt R., Jouguey S., Delevallee F., Flahaut M. Release of prostaglandins E and F in a algogenic reaction and its inhibition. European Journal of Pharmacology . 1980;5:17–24. doi: 10.1016/0014-2999(80)90377-5. [DOI] [PubMed] [Google Scholar]
  • 63.Reisine T., pasternack G. Goodman and Gilman Pharmacological Basis of Therapeutics . 9th ed. New York, USA: McGraw-Hill; 1996. [Google Scholar]
  • 64.Katzung B. G. Basic and Clinical Pharmacology . 6th ed. Connecticut, USA: Appleton and Lange; 2005. [Google Scholar]
  • 65.Ahmadiani A., Fereidoni M., Semnanian S., Kamalinejad M., Saremi S. Antinociceptive and anti-inflammatory effects of Sambucus ebulus rhizome extract in rats. Journal of Ethnopharmacology . 1998;61(3):229–235. doi: 10.1016/s0378-8741(98)00043-9. [DOI] [PubMed] [Google Scholar]
  • 66.Peraman M. K., Ramalingam P., Bapatla J. N. N. Anti-inflammatory and antimicrobial activities of the extracts of Edipta alba leaves. European Journal of Experimental Biology . 2011;1:172–177. [Google Scholar]
  • 67.Opie E. L. On the relation of necrosis and inflammation to denaturation of proteins. Journal of Experimental Medicine . 1962;115(3):597–608. doi: 10.1084/jem.115.3.597. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data used to support the study are included in the paper.


Articles from Advances in Pharmacological and Pharmaceutical Sciences are provided here courtesy of Wiley

RESOURCES